drugset / Trial / NCT00328926
Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Sponsor has decided to discontinue Luveris® in the United States (US) due to level of customer demand for this product, and not due to any efficacy or safety concerns.
Timeline
- Start
- 2006-03
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Luveris | Protein / enzyme biologic | 25 iu | Subcutaneous |
| Comparator | Luveris | Protein / enzyme biologic | 75 iu | Subcutaneous |
| Comparator | Gonal-f | Protein / enzyme biologic | 75 iu | Subcutaneous |
| Comparator | Gonal-f | Protein / enzyme biologic | 150 iu | Subcutaneous |
| Comparator | Gonal-f | Protein / enzyme biologic | 225 iu | Subcutaneous |
| Comparator | Ovidrel | Protein / enzyme biologic | 250 ug | Subcutaneous |